Current Treatment Options in Oncology

, Volume 13, Issue 2, pp 146–160 | Cite as

Oncofertility and the Male Cancer Patient

Oncofertility (JS Jeruss, Section Editor)

Opinion statement

Oncofertility as a discipline plays an important, adjunctive role in the treatment of male patients with cancer. Despite recommendations by the American Society of Clinical Oncology, many clinicians managing malignancies in males fail to consistently incorporate fertility preservation as a routine aspect of health care. Providers involved in the treatment of oncologic patients should have an awareness of the impact of their prescribed treatments on reproductive potential, just as they would be knowledgeable of the potential deleterious effects of cancer therapies on vital organs such as the kidneys, lungs, and liver. Providers should then have a discussion with their patients regarding these potential adverse therapeutic effects or consult a fertility preservation specialist to discuss these matters and fertility preservation options with the patient. Cryopreservation of sperm remains an excellent option for male fertility preservation as it is readily available and results in storage of viable gametes for future use in the event of post treatment infertility. With the use of assisted reproductive techniques (ART), cryopreserved sperm may ultimately result in successful paternity, even in the setting of very low numbers of stored sperm. While sperm cryopreservation is usually an option for adolescent and adult males, fertility preservation in pre-pubertal males presents a more challenging problem. To date, no clinically proven methods are available to preserve fertility in these males. However, some centers do offer experimental protocols under the oversight of an IRB, such as testicular tissue cryopreservation in these males. The hope is that one day science will provide a mechanism for immature germ cells from the testicular tissue of these patients to be used in vivo or in vitro to facilitate reproduction. In closing, studies have shown that the patient’s regard for his provider is enhanced when the issue fertility preservation is raised. While oncologic care is often fraught with time constraints and acute medical concerns, fertility preservation care in the male can typically be administered quickly and without disruption of the overall plan of care.


Oncofertility Male patients Cancer Assisted reproductive techniques Cryopreservation 



Assisted reproductive techniques


American Society of Clinical Oncology


American Society for Reproductive Medicine


Follicle stimulating hormone


Gonadotropic releasing hormone




Human chorionic gonadotropin


In-vitro fertilization


Intracytoplasmic sperm injection


Luteinizing hormone


Retroperitoneal lymph node dissection

References and Recommended Readings

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER Cancer Statistics Review. National Cancer Institute, 1975–2008Google Scholar
  2. 2.
    Bleyer A. Young adult oncology: the patients and their survival challenges. CA Cancer J Clin. 2007;57:242.PubMedCrossRefGoogle Scholar
  3. 3.
    Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572.PubMedCrossRefGoogle Scholar
  4. 4.
    Schover LR. Motivation for parenthood after cancer: a review. Journal of the National Cancer Institute. Monographs, 2, 2005Google Scholar
  5. 5.•
    Ginsberg JP, Carlson CA, Lin K et al. An experimental protocol for fertility preservation in prepubertal boys recently diagnosed with cancer: a report of acceptability and safety. Human Reproduction. 2010;25:37. Outlines a current protocol for experimental testicular cryopreservation in prepubertal boys. It is noteworthy that current ASRM / ASCO recommendations stipulate that testicular tissue cryopreservation in prepubertal boys should only be performed in the setting of an IRB-approved experimental protocol such as this. PubMedCrossRefGoogle Scholar
  6. 6.
    Mertens AC, Yasui Y, Neglia JP, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2001;19:3163.Google Scholar
  7. 7.
    Fertility preservation and reproduction in cancer patients. Fertility and Sterility. 2005;83:1622Google Scholar
  8. 8.
    Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2006;24:2917.CrossRefGoogle Scholar
  9. 9.
    Green DM, Kawashima T, Stovall M, et al. Fertility of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2010;28:332.CrossRefGoogle Scholar
  10. 10.
    Muller J, Skakkebaek NE. Quantification of germ cells and seminiferous tubules by stereological examination of testicles from 50 boys who suffered from sudden death. Int J Androl. 1983;6:143.PubMedCrossRefGoogle Scholar
  11. 11.
    Clermont Y. The cycle of the seminiferous epithelium in man. Am J Anat. 1963;112:35.PubMedCrossRefGoogle Scholar
  12. 12.
    Clermont Y. Spermatogenesis in man. A study of the spermatogonial population. Fertility and Sterility. 1966;17:705Google Scholar
  13. 13.
    Clermont Y. Renewal of spermatogonia in man. Am J Anat. 1966;118:509.PubMedCrossRefGoogle Scholar
  14. 14.•
    Jahnukainen K, Ehmcke J, Hou M et al. Testicular function and fertility preservation in male cancer patients. Best practice & research. Clinical Endocrinology & Metabolism. 2011;25:287. Review of the anatomy and physiology of pre-pubertal and pubertal males in relation to oncofertility.CrossRefGoogle Scholar
  15. 15.
    Ehmcke J, Hubner K, Scholer HR, et al. Spermatogonia: origin, physiology and prospects for conservation and manipulation of the male germ line. Reprod Fertil Dev. 2006;18:7.PubMedCrossRefGoogle Scholar
  16. 16.
    Ehmcke J, Wistuba J, Schlatt S. Spermatogonial stem cells: questions, models and perspectives. Hum Reprod Updat. 2006;12:275.CrossRefGoogle Scholar
  17. 17.
    Meachem S, von Schonfeldt V, Schlatt S. Spermatogonia: stem cells with a great perspective. Reproduction. 2001;121:825.PubMedCrossRefGoogle Scholar
  18. 18.
    Clermont Y, Leblond CP. Differentiation and renewal of spermatogonia in the monkey, Macacus rhesus. Am J Anat. 1959;104:237.PubMedCrossRefGoogle Scholar
  19. 19.
    Clermont Y. Two classes of spermatogonial stem cells in the monkey (Cercopithecus aethiops). Am J Anat. 1969;126:57.PubMedCrossRefGoogle Scholar
  20. 20.
    Simorangkir DR, Marshall GR, Ehmcke J, et al. Prepubertal expansion of dark and pale type A spermatogonia in the rhesus monkey (Macaca mulatta) results from proliferation during infantile and juvenile development in a relatively gonadotropin independent manner. Biol Reprod. 2005;73:1109.PubMedCrossRefGoogle Scholar
  21. 21.
    van Alphen MM, van de Kant HJ, Davids JA, et al. Dose-response studies on the spermatogonial stem cells of the rhesus monkey (Macaca mulatta) after X irradiation. Radiat Res. 1989;119:443.PubMedCrossRefGoogle Scholar
  22. 22.
    van Alphen MM, van de Kant HJ, de Rooij DG. Repopulation of the seminiferous epithelium of the rhesus monkey after X irradiation. Radiat Res. 1988;113:487.PubMedCrossRefGoogle Scholar
  23. 23.
    Kanatsu-Shinohara M, Toyokuni S, Morimoto T, et al. Functional assessment of self-renewal activity of male germline stem cells following cytotoxic damage and serial transplantation. Biol Reprod. 2003;68:1801.PubMedCrossRefGoogle Scholar
  24. 24.
    Ogawa T, Ohmura M, Yumura Y, et al. Expansion of murine spermatogonial stem cells through serial transplantation. Biol Reprod. 2003;68:316.PubMedCrossRefGoogle Scholar
  25. 25.•
    Dohle GR. Male infertility in cancer patients: Review of the literature. International journal of urology: official journal of the Japanese Urological Association. 2010;17:327. Provides a concise review of infertility in the male cancer patient. CrossRefGoogle Scholar
  26. 26.
    Sabanegh Jr ES, Ragheb AM. Male fertility after cancer. Urology. 2009;73:225.PubMedCrossRefGoogle Scholar
  27. 27.
    Hallak J, Kolettis PN, Sekhon VS, et al. Cryopreservation of sperm from patients with leukemia: is it worth the effort? Cancer. 1999;85:1973.PubMedGoogle Scholar
  28. 28.
    Berthelsen JG, Skakkebaek NE. Gonadal function in men with testis cancer. Fertil Steril. 1983;39:68.PubMedGoogle Scholar
  29. 29.
    Rueffer U, Breuer K, Josting A, et al. Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment. Annals of Oncology: Official Journal of the European Society for Medical Oncology / ESMO. 2001;12:1307.CrossRefGoogle Scholar
  30. 30.
    Schover LR, Brey K, Lichtin A, et al. Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2002;20:1880.CrossRefGoogle Scholar
  31. 31.
    Tempest HG, Ko E, Chan P, et al. Sperm aneuploidy frequencies analysed before and after chemotherapy in testicular cancer and Hodgkin's lymphoma patients. Hum Reprod. 2008;23:251.PubMedCrossRefGoogle Scholar
  32. 32.
    Vigersky RA, Chapman RM, Berenberg J, et al. Testicular dysfunction in untreated Hodgkin's disease. Am J Med. 1982;73:482.PubMedCrossRefGoogle Scholar
  33. 33.
    Petersen PM, Skakkebaek NE, Vistisen K, et al. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 1999;17:941.Google Scholar
  34. 34.
    Foster RS, McNulty A, Rubin LR, et al. The fertility of patients with clinical stage I testis cancer managed by nerve sparing retroperitoneal lymph node dissection. J Urol. 1994;152:1139.PubMedGoogle Scholar
  35. 35.
    Liguori G, Trombetta C, Bucci S et al. Semen quality before and after orchiectomy in men with testicular cancer. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia. 2008;80:99Google Scholar
  36. 36.
    Herr HW, Bar-Chama N, O'Sullivan M, et al. Paternity in men with stage I testis tumors on surveillance. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 1998;16:733.Google Scholar
  37. 37.
    Sklar C. Reproductive physiology and treatment-related loss of sex hormone production. Medical and Pediatric Oncology. 1999;33:2.PubMedCrossRefGoogle Scholar
  38. 38.
    van Alphen MM, van de Kant HJ, de Rooij DG. Depletion of the spermatogonia from the seminiferous epithelium of the rhesus monkey after X irradiation. Radiat Res. 1988;113:473.PubMedCrossRefGoogle Scholar
  39. 39.
    de Rooij DG, van de Kant HJ, Dol R, et al. Long-term effects of irradiation before adulthood on reproductive function in the male rhesus monkey. Biol Reprod. 2002;66:486.PubMedCrossRefGoogle Scholar
  40. 40.
    Meseguer M, Garrido N, Remohi J, et al. Testicular sperm extraction (TESE) and ICSI in patients with permanent azoospermia after chemotherapy. Hum Reprod. 2003;18:1281.PubMedCrossRefGoogle Scholar
  41. 41.
    Kenney LB, Laufer MR, Grant FD, et al. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer. 2001;91:613.PubMedCrossRefGoogle Scholar
  42. 42.
    van Casteren NJ, van der Linden GH, Hakvoort-Cammel FG, et al. Effect of childhood cancer treatment on fertility markers in adult male long-term survivors. Pediatric Blood & Cancer. 2009;52:108.CrossRefGoogle Scholar
  43. 43.
    Centola GM, Keller JW, Henzler M, et al. Effect of low-dose testicular irradiation on sperm count and fertility in patients with testicular seminoma. J Androl. 1994;15:608.PubMedGoogle Scholar
  44. 44.
    Ash P. The influence of radiation on fertility in man. Br J Radiol. 1980;53:271.PubMedCrossRefGoogle Scholar
  45. 45.
    Pryant RM, Meistrich ML, Wilson G, et al. Long-term reduction in sperm count after chemotherapy with and without radiation for Non-Hodgkin's lymphomas. J Clin Oncol. 1993;11:239.Google Scholar
  46. 46.
    Howell S, Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin N Am. 1998;27:927.CrossRefGoogle Scholar
  47. 47.
    Hart R. Preservation of fertility in adults and children diagnosed with cancer. BMJ. 2008;337:a2045.PubMedCrossRefGoogle Scholar
  48. 48.
    Sandeman TF. The effects of x irradiation on male human fertility. Br J Radiol. 1966;39:901.PubMedCrossRefGoogle Scholar
  49. 49.
    Hahn EW, Feingold SM, Simpson L, et al. Recovery from aspermia induced by low-dose radiation in seminoma patients. Cancer. 1982;50:337.PubMedCrossRefGoogle Scholar
  50. 50.
    Anserini P, Chiodi S, Spinelli S et al. Semen analysis following allogeneic bone marrow transplantation. Additional data for evidence-based counselling. Bone Marrow Transplantation. 2002;30:447Google Scholar
  51. 51.
    Shalet SM, Tsatsoulis A, Whitehead E, et al. Vulnerability of the human Leydig cell to radiation damage is dependent upon age. J Endocrinol. 1989;120:161.PubMedCrossRefGoogle Scholar
  52. 52.
    Brauner R, Czernichow P, Cramer P, et al. Leydig-cell function in children after direct testicular irradiation for acute lymphoblastic leukemia. N Engl J Med. 1983;309:25.PubMedCrossRefGoogle Scholar
  53. 53.
    Sklar CA, Robison LL, Nesbit ME, et al. Effects of radiation on testicular function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Children Cancer Study Group. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 1990;8:1981.Google Scholar
  54. 54.
    Sarafoglou K, Boulad F, Gillio A, et al. Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr. 1997;130:210.PubMedCrossRefGoogle Scholar
  55. 55.
    Waxman J. Chemotherapy and the adult gonad: a review. Journal of the Royal Society of Medicine. 1983;76:144.PubMedGoogle Scholar
  56. 56.
    Waxman J, Terry Y, Rees LH, et al. Gonadal function in men treated for acute leukaemia. British Medical Journal. 1983;287:1093.PubMedCrossRefGoogle Scholar
  57. 57.
    Waxman JH, Terry YA, Wrigley PF, et al. Gonadal function in Hodgkin's disease: long-term follow-up of chemotherapy. British Medical Journal. 1982;285:1612.PubMedCrossRefGoogle Scholar
  58. 58.
    Nurmio M, Keros V, Lahteenmaki P, et al. Effect of childhood acute lymphoblastic leukemia therapy on spermatogonia populations and future fertility. J Clin Endocrinol Metab. 2009;94:2119.PubMedCrossRefGoogle Scholar
  59. 59.
    Kreuser ED, Xiros N, Hetzel WD, et al. Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin's disease. J Cancer Res Clin Oncol. 1987;113:260.PubMedCrossRefGoogle Scholar
  60. 60.
    Meistrich ML, Wilson G, Brown BW, et al. Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas. Cancer. 1992;70:2703.PubMedCrossRefGoogle Scholar
  61. 61.
    Bokemeyer C, Schmoll HJ, van Rhee J, et al. Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma. Ann Hematol. 1994;68:105.PubMedCrossRefGoogle Scholar
  62. 62.
    Ridola V, Fawaz O, Aubier F, et al. Testicular function of survivors of childhood cancer: a comparative study between ifosfamide- and cyclophosphamide-based regimens. Eur J Cancer. 2009;45:814.PubMedCrossRefGoogle Scholar
  63. 63.
    Lampe H, Horwich A, Norman A, et al. Fertility after chemotherapy for testicular germ cell cancers. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 1997;15:239.Google Scholar
  64. 64.
    Pectasides D, Pectasides M, Farmakis D, et al. Testicular function in patients with testicular cancer treated with bleomycin-etoposide-carboplatin (BEC(90)) combination chemotherapy. Eur Urol. 2004;45:187.PubMedCrossRefGoogle Scholar
  65. 65.
    Nalesnik JG, Sabanegh Jr ES, Eng TY, et al. Fertility in men after treatment for stage 1 and 2A seminoma. Am J Clin Oncol. 2004;27:584.PubMedCrossRefGoogle Scholar
  66. 66.
    Fossa SD, Horwich A, Russell JM et al. Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 1999;17:1146Google Scholar
  67. 67.
    Jacobsen KD, Olsen DR, Fossa K, et al. External beam abdominal radiotherapy in patients with seminoma stage I: field type, testicular dose, and spermatogenesis. Int J Radiat Oncol Biol Phys. 1997;38:95.PubMedCrossRefGoogle Scholar
  68. 68.
    Littley MD, Shalet SM, Beardwell CG, et al. Radiation-induced hypopituitarism is dose-dependent. Clin Endocrinol. 1989;31:363.CrossRefGoogle Scholar
  69. 69.
    Muller J, Sonksen J, Sommer P, et al. Cryopreservation of semen from pubertal boys with cancer. Medical and Pediatric Oncology. 2000;34:191.PubMedCrossRefGoogle Scholar
  70. 70.
    Hovav Y, Dan-Goor M, Yaffe H, et al. Electroejaculation before chemotherapy in adolescents and young men with cancer. Fertil Steril. 2001;75:811.PubMedCrossRefGoogle Scholar
  71. 71.
    Hourvitz A, Goldschlag DE, Davis OK, et al. Intracytoplasmic sperm injection (ICSI) using cryopreserved sperm from men with malignant neoplasm yields high pregnancy rates. Fertil Steril. 2008;90:557.PubMedCrossRefGoogle Scholar
  72. 72.
    Hallak J, Hendin BN, Thomas Jr AJ, et al. Investigation of fertilizing capacity of cryopreserved spermatozoa from patients with cancer. J Urol. 1998;159:1217.PubMedCrossRefGoogle Scholar
  73. 73.
    Li FP, Fine W, Jaffe N, et al. Offspring of patients treated for cancer in childhood. Journal of the National Cancer Institute. 1979;62:1193.PubMedGoogle Scholar
  74. 74.
    Byrne J, Rasmussen SA, Steinhorn SC, et al. Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am J Hum Genet. 1998;62:45.PubMedCrossRefGoogle Scholar
  75. 75.
    van Casteren NJ, van Santbrink EJ, van Inzen W, et al. Use rate and assisted reproduction technologies outcome of cryopreserved semen from 629 cancer patients. Fertil Steril. 2008;90:2245.PubMedCrossRefGoogle Scholar
  76. 76.
    Meseguer M, Molina N, Garcia-Velasco JA, et al. Sperm cryopreservation in oncological patients: a 14-year follow-up study. Fertil Steril. 2006;85:640.PubMedCrossRefGoogle Scholar
  77. 77.
    Zorn B, Virant-Klun I, Stanovnik M, et al. Intracytoplasmic sperm injection by testicular sperm in patients with aspermia or azoospermia after cancer treatment. Int J Androl. 2006;29:521.PubMedCrossRefGoogle Scholar
  78. 78.
    Schover LR, Brey K, Lichtin A, et al. Oncologists' attitudes and practices regarding banking sperm before cancer treatment. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2002;20:1890.CrossRefGoogle Scholar
  79. 79.
    Goodwin T, Elizabeth Oosterhuis B, Kiernan M, et al. Attitudes and practices of pediatric oncology providers regarding fertility issues. Pediatric Blood & Cancer. 2007;48:80.CrossRefGoogle Scholar
  80. 80.
    Quinn GP, Vadaparampil ST, Gwede CK, et al. Discussion of fertility preservation with newly diagnosed patients: oncologists' views. Journal of Cancer Survivorship: Research and Practice. 2007;1:146.CrossRefGoogle Scholar
  81. 81.•
    Quinn GP, Vadaparampil ST, Lee JH et al. Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2009;27:5952. Recent reviews of referral patterns among oncologists to reproductive specialists. These articles highlight the ongoing impediments to routine implementation of fertility preservation in oncology practices. CrossRefGoogle Scholar
  82. 82.•
    Forman EJ, Anders CK, Behera MA. A nationwide survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients. Fertility and Sterility. 2010;94:1652. Recent reviews of referral patterns among oncologists to reproductive specialists. These articles highlight the ongoing impediments to routine implementation of fertility preservation in oncology practices.PubMedCrossRefGoogle Scholar
  83. 83.
    Sheth KR, Sharma V, Helfand BT, Cashy J, Smith K, Hedges JC, Kohler TS, Woodruff TK, Brannigan RE. Improved fertility preservation care for male patients with cancer after establishment of a formalized oncofertility program. J Urol. 2012;187:979.PubMedCrossRefGoogle Scholar
  84. 84.
    Rieker PP, Fitzgerald EM, Kalish LA. Adaptive behavioral responses to potential infertility among survivors of testis cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 1990;8:347.Google Scholar
  85. 85.
    Green D, Galvin H, Horne B. The psycho-social impact of infertility on young male cancer survivors: a qualitative investigation. Psycho-Oncology. 2003;12:141.PubMedCrossRefGoogle Scholar
  86. 86.
    Gurevich M, Bishop S, Bower J, et al. (Dis)embodying gender and sexuality in testicular cancer. Social Science & Medicine. 2004;58:1597.CrossRefGoogle Scholar
  87. 87.
    Saito K, Suzuki K, Iwasaki A, et al. Sperm cryopreservation before cancer chemotherapy helps in the emotional battle against cancer. Cancer. 2005;104:521.PubMedCrossRefGoogle Scholar
  88. 88.
    The Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertility and Sterility. 2005;83:1622.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of UrologyMayo ClinicRochesterUSA
  2. 2.Department of UrologyNorthwestern University, Feinberg School of MedicineChicagoUSA

Personalised recommendations